Stockreport

Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel

Alzamend Neuro, Inc.  (ALZN) 
PDF ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the t [Read more]